Seema Sheoran
Stock Analyst at Rodman & Renshaw
(1.77)
# 3,427
Out of 5,090 analysts
7
Total ratings
42.9%
Success rate
1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Seema Sheoran
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IRLA IRulya Therapeutics | Initiated Coverage: Buy | $70 | $32.95 | +112.44% | 1 | Sep 24, 2026 | |
| ELDN Eledon Pharmaceuticals | Initiated Coverage: Buy | $12 | $2.77 | +333.21% | 1 | Jul 21, 2026 | |
| NGNE Neurogene | Initiated Coverage: Buy | $70 | $27.55 | +154.08% | 1 | Jun 3, 2026 | |
| AVXL Anavex Life Sciences | Initiated Coverage: Buy | $20 | $1.19 | +1,580.67% | 1 | May 4, 2026 | |
| CAMP Camp4 Therapeutics | Initiated Coverage: Buy | $7 | $3.96 | +76.77% | 1 | Apr 14, 2026 | |
| SABS SAB Biotherapeutics | Initiated Coverage: Buy | $13 | $3.35 | +288.06% | 1 | Apr 2, 2026 | |
| SGMT Sagimet Biosciences | Initiated Coverage: Buy | $28 | $9.92 | +182.26% | 1 | Mar 26, 2026 |
IRulya Therapeutics
Sep 24, 2026
Initiated Coverage: Buy
Price Target: $70
Current: $32.95
Upside: +112.44%
Eledon Pharmaceuticals
Jul 21, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $2.77
Upside: +333.21%
Neurogene
Jun 3, 2026
Initiated Coverage: Buy
Price Target: $70
Current: $27.55
Upside: +154.08%
Anavex Life Sciences
May 4, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $1.19
Upside: +1,580.67%
Camp4 Therapeutics
Apr 14, 2026
Initiated Coverage: Buy
Price Target: $7
Current: $3.96
Upside: +76.77%
SAB Biotherapeutics
Apr 2, 2026
Initiated Coverage: Buy
Price Target: $13
Current: $3.35
Upside: +288.06%
Sagimet Biosciences
Mar 26, 2026
Initiated Coverage: Buy
Price Target: $28
Current: $9.92
Upside: +182.26%